Brief: Merus NV Says FY Basic And Diluted Loss Per Share $2.92

Merus NV

28/02/2023 21:36

Feb 28 (Reuters) - Merus NV  MRUS.O :
    * FY BASIC AND DILUTED LOSS PER SHARE $2.92 (CORRECTS
METRIC)
    * MERUS ANNOUNCES FINANCIAL RESULTS FOR THE FOURTH QUARTER
AND
FULL YEAR 2022 AND PROVIDES BUSINESS UPDATE
    * ZENOCUTUZUMAB (ZENO) IN NRG1+ CANCER POTENTIAL
REGISTRATIONAL
PATH AND TIMELINE UPDATE PLANNED FOR FIRST HALF OF 2023
    * PETOSEMTAMAB CLINICAL AND REGULATORY UPDATE PLANNED FOR
FIRST
HALF OF 2023
    * MCLA-129 CLINICAL UPDATE PLANNED FOR SECOND HALF OF 2023
    * EXISTING CASH, CASH EQUIVALENTS AND MARKETABLE SECURITIES
EXPECTED TO FUND MERUS' OPERATIONS INTO SECOND HALF 2025

Source text for Eikon: [ID: nGNX5VZRRP]
Further company coverage:  MRUS.O 

 ((Reuters.Briefs@thomsonreuters.com;))